A Novel Planar Crypt Microarray for Real-Time Evaluation of Human Intestinal Stem Cell Fate

用于实时评估人类肠道干细胞命运的新型平面隐窝微阵列

基本信息

  • 批准号:
    10436268
  • 负责人:
  • 金额:
    $ 5.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, affect an estimated 3.1 million U.S. adults. IBD pathophysiology is complex and involves genetic, environmental, and immune responses as well as alterations in gut microbial short-chain fatty acid (SCFA) levels. Recent studies from the Magness lab in murine ileal organoids demonstrated that exposure to IL-22 favors progenitor cell expansion over intestinal stem cell (ISC) self-renewal, and this phenotype is thought be regulated by activating Signal Transducer and Activator of Transcription (STAT)-3. Further, new evidence has shown that the gut microbial SCFA, butyrate, enhances IL-22 receptor expression and IL-22-induced activation of STAT3 in human colon cancer cells. While mouse, organoid, and cancer cell lines have helped to advance the field, more physiologically relevant in vitro human models are needed to increase accuracy and resolution of experiments aimed at predicting and uncovering the response of human gut ISCs and differentiated epithelium to such IBD-relevant factors. My aims will use a novel planar crypt-microarray (PCM) device and reporter cell lines to live-image primary human colonic stem cells during their response to IBD-related perturbations. PCMs have already been optimized for culture of mouse ISCs, and preliminary data demonstrates human ISC compatibility. Aim 1 will adjust factors such as PCM membrane composition, thickness, and timing of apical/basal media changes to promote confluent monolayers and compartmentalization of stem (Olfm4-EGFP) and differentiated (Muc2-BFP) cell zones. Using human-optimized PCMs, I will test the central hypothesis that butyrate-stimulated IL-22 signaling enhances asymmetric division and differentiation in human colonic ISCs. Aim 2 will use CRISPR/Cas9 indels to induce a frameshift loss-of-function (LOF) mutation in IL-22 receptor subunit alpha 1 into a tetracycline-inducible H2B::RFP (tetO-H2B::RFP) human colon stem cell line to test whether IL-22 signaling is necessary for asymmetric division. The tetO-H2B::RFP fusion protein allows for controlled, sensitive analysis of cell division dynamics in mammalian cells, with rapidly dividing cells corresponding to diluted RFP fluorescence intensity over time. RFP label-retaining cells will be assessed for phosphorylated STAT3 (pSTAT3) via immunofluorescence imaging on unsorted cell monolayers and for perturbed lineage pathways by FACS-scRNA-seq. The LOF model will be compared against IL22RA1+ controls on PCMs to determine if asymmetric division is enhanced by butyrate-stimulated IL-22 signaling. Our lab already has preliminary data for Olfm4-EGFP and H2B reporter lines. In the outstanding training environment in Dr. Scott Magness’ group at the University of North Carolina at Chapel Hill, I will gain expertise in microfabrication and intestinal stem cell biology and learn new techniques in primary human colon stem cell culture, single-cell biology/genomics, and bioinformatics. My career development training plan focuses on research skills, professional development, and clinical skills to promote my path to independence as an academic physician-scientist.
项目摘要 炎症性肠病(IBD),包括克罗恩病和溃疡性结肠炎,估计有3.1 美国成年人。 以及肠道短链脂肪酸(SCFA)水平的改变。 在鼠回肠或ganoids中,暴露辛苦22促进祖细胞细胞的扩张比肠道扩张 干细胞(ISC)自我更新,该表型是通过激活信号传感器和 转录激活剂(Stat)-3。 增强IL-22受体表达和IL-22诱导的人类结肠癌细胞的激活 小鼠,器官和癌细胞lins有助于发展领域,更多的生理学在体外相关 需要人类模型来提高旨在预测和的实验的准确性和分辨率 揭示了人类肠道ISC的反应,并分化了上皮对这种与IBD相关的因素。 我的目标将平面颅骨cranar Crypt-Microarray(PCM)设备和记者细胞系进行活图像主体 在对IBD相关扰动的反应过程中,人类结肠干细胞。 对于小鼠的培养物,预启示数据证明了人类ISC的兼容性。 例如PCM膜组成,厚度和顶端/基础介质的变化以促进汇合 使用茎(OLFM4-EGFP)和分化(MUC2-BFP)细胞区的单层和分室化 人类优化的PCM,我将测试中心假设,即丁酸酯刺激的IL-22信号增强了 人类ISC中的不对称分裂和差异 在IL-22受体亚基1中诱导功能丧失(LOF)突变,进入四环素诱导 H2B :: RFP(TETO-H2B :: RFP)人类结肠干细胞系以测试IL-22信号是否需要 不对称分裂。 Mamalian细胞的动力学,迅速分裂的细胞Corresspond逐渐稀释的RFP荧光强度 时间。 通过FACS-SCRNA-SEQ对未分类的细胞单层和Fortuster的谱系途径进行成像 将与PCMS上的IL22RA1+对照进行比较,以确定是否通过 丁酸酯刺激的IL-22信号传导已经具有OLFM4-EGFP和H2B记者线的预启示数据。 在北卡罗琳宇宙的Scott Magness博士小组的出色培训环境中 希尔,我将获得微加工和肠干细胞生物学的专业知识,并在初级学习新技术 人类的干细胞培养,单细胞生物学/基因组学和生物信息学。 计划重点介绍研究技能,专业发展和临床技能,以促进我的独立道路 作为学术医师科学家。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Meryem Tyrrasch Ok其他文献

Meryem Tyrrasch Ok的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Meryem Tyrrasch Ok', 18)}}的其他基金

A Novel Planar Crypt Microarray for Real-Time Evaluation of Human Intestinal Stem Cell Fate
用于实时评估人类肠道干细胞命运的新型平面隐窝微阵列
  • 批准号:
    10163670
  • 财政年份:
    2020
  • 资助金额:
    $ 5.27万
  • 项目类别:

相似国自然基金

依恋相关情景模拟对成人依恋安全感的影响及机制
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    56 万元
  • 项目类别:
    面上项目
成人与儿童结核病发展的综合研究:细菌菌株和周围微生物组的影响
  • 批准号:
    81961138012
  • 批准年份:
    2019
  • 资助金额:
    100 万元
  • 项目类别:
    国际(地区)合作与交流项目
统计学习影响成人汉语二语学习的认知神经机制
  • 批准号:
    31900778
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
  • 批准号:
    10752276
  • 财政年份:
    2024
  • 资助金额:
    $ 5.27万
  • 项目类别:
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
  • 批准号:
    10595404
  • 财政年份:
    2023
  • 资助金额:
    $ 5.27万
  • 项目类别:
Targeting Menin in Acute Leukemia with Upregulated HOX Genes
通过上调 HOX 基因靶向急性白血病中的 Menin
  • 批准号:
    10655162
  • 财政年份:
    2023
  • 资助金额:
    $ 5.27万
  • 项目类别:
Mechanisms of Mammalian Genetic Hearing Loss
哺乳动物遗传性听力损失的机制
  • 批准号:
    10660134
  • 财政年份:
    2023
  • 资助金额:
    $ 5.27万
  • 项目类别:
3D Methodology for Interpreting Disease-Associated Genomic Variation in RAG2
解释 RAG2 中疾病相关基因组变异的 3D 方法
  • 批准号:
    10724152
  • 财政年份:
    2023
  • 资助金额:
    $ 5.27万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了